First-in-class drug holds promise for therapy-resistant breast cancer - Science Daily

Science Daily

First-in-class drug holds promise for therapy-resistant breast cancer Science Daily "This is a fundamentally different, new class of agents for estrogen-receptor-positive breast cancer," said Dr. Ganesh Raj, Professor of Urology and Pharmacology at UT Southwestern's Harold C. Simmons Comprehensive Cancer Center."Its unique ... and more »

from # All Medicine by Alexandros G. Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2vn4tUr
via IFTTT